Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Gastrectomy | Case report

Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family

Authors: Elisabeth Niemeyer, Hamid Mofid, Carsten Zornig, Eike-Christian Burandt, Alexander Stein, Andreas Block, Alexander E. Volk

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Hereditary diffuse gastric cancer is a rare condition that accounts for approximately 1–3% of all gastric cancer cases. Due to its rapid and invasive growth pattern, it is associated with a very poor prognosis. As a result, comprehensive genetic testing is imperative in patients who meet the current testing criteria in order to identify relatives at risk. This case report illustrates the substantial benefit of genetic testing in the family of a patient diagnosed with hereditary diffuse gastric cancer.

Case presentation

A 37-year-old patient was admitted to the emergency department with acute abdominal pain. Following explorative laparoscopy, locally advanced diffuse gastric cancer was diagnosed. The indication for genetic testing of CDH1 was given due to the patient’s young age. A germline mutation in CDH1 was identified in the index patient. As a result, several family members underwent genetic testing. The patient’s father, brother and one aunt were identified as carriers of the familial CDH1 mutation and subsequently received gastrectomy. In both the father and the aunt, histology of the surgical specimen revealed a diffuse growing adenocarcinoma after an unremarkable preoperative gastroscopy.

Conclusion

Awareness and recognition of a potential hereditary diffuse gastric cancer can provide a substantial health benefit not only for the patient but especially for affected family members.
Literature
1.
go back to reference Rawla P, et al. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.PubMed Rawla P, et al. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26–38.PubMed
2.
go back to reference Lauren P. The two histological main types of gastric cancer: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand. 1965;64:331–49.CrossRef Lauren P. The two histological main types of gastric cancer: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand. 1965;64:331–49.CrossRef
3.
go back to reference Junli MA, et al. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11(5):2959–64.CrossRef Junli MA, et al. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11(5):2959–64.CrossRef
4.
go back to reference Lee JY, et al. The characteristics and prognosis of diffuse-type early gastric cancer diagnosed during health check-ups. Gut Liver. 2017;11(6):807–12.CrossRef Lee JY, et al. The characteristics and prognosis of diffuse-type early gastric cancer diagnosed during health check-ups. Gut Liver. 2017;11(6):807–12.CrossRef
5.
go back to reference van der Post RS, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361–74.CrossRef van der Post RS, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361–74.CrossRef
6.
go back to reference Kaurah P, et al. Hereditary diffuse gastric cancer. Seattle: GeneReviews®, University of Washington; 2002. 1993-2020. [last updated 2018 Mar 22]. Kaurah P, et al. Hereditary diffuse gastric cancer. Seattle: GeneReviews®, University of Washington; 2002. 1993-2020. [last updated 2018 Mar 22].
7.
go back to reference Weren RDA, et al. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet. 2018;55:669–74.CrossRef Weren RDA, et al. Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility. J Med Genet. 2018;55:669–74.CrossRef
8.
go back to reference Sánchez-Tilló E, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;2010(29):3490–500.CrossRef Sánchez-Tilló E, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;2010(29):3490–500.CrossRef
9.
go back to reference Fitzgerald RC, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436–44.CrossRef Fitzgerald RC, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436–44.CrossRef
10.
go back to reference Shenoy S. CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 2019;11:10477–86.CrossRef Shenoy S. CDH1 (E-cadherin) mutation and gastric cancer: genetics, molecular mechanisms and guidelines for management. Cancer Manag Res. 2019;11:10477–86.CrossRef
11.
go back to reference Rocha JP, et al. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology. 2018;73(6):878–86.CrossRef Rocha JP, et al. Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management. Histopathology. 2018;73(6):878–86.CrossRef
12.
go back to reference Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon K, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. J Natl Compr Canc Netw. 2017;15(1):9-20. Retrieved Apr 27, 2020, from http://www.jnccn.org/view/journals/jnccn/15/1/article-p9.xml. Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon K, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow S. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. J Natl Compr Canc Netw. 2017;15(1):9-20. Retrieved Apr 27, 2020, from http://​www.​jnccn.​org/​view/​journals/​jnccn/​15/​1/​article-p9.​xml.
13.
go back to reference Porter AJ, et al. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol. 2014;58:1–10.CrossRef Porter AJ, et al. Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol. 2014;58:1–10.CrossRef
14.
go back to reference Grady W, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16–7.CrossRef Grady W, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16–7.CrossRef
15.
go back to reference Krempely K, et al. A novel de novo CDH1 germline variant aids in the classification of carboxy-terminal E-cadherin alterations predicted to escape nonsense-mediated mRNA decay. Cold Spring Harb Mol Case Stud. 2018;4(4):1–8. Krempely K, et al. A novel de novo CDH1 germline variant aids in the classification of carboxy-terminal E-cadherin alterations predicted to escape nonsense-mediated mRNA decay. Cold Spring Harb Mol Case Stud. 2018;4(4):1–8.
16.
go back to reference Frebourg T, et al. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet. 2006;43(2):138–42.CrossRef Frebourg T, et al. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet. 2006;43(2):138–42.CrossRef
17.
go back to reference Wickremeratne T, et al. Prophylactic gastrectomy in a 16-year-old. Eur J Gastroenterol Hepatol. 2014;26(3):353–6.CrossRef Wickremeratne T, et al. Prophylactic gastrectomy in a 16-year-old. Eur J Gastroenterol Hepatol. 2014;26(3):353–6.CrossRef
18.
go back to reference Guilford P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRef Guilford P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRef
Metadata
Title
Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family
Authors
Elisabeth Niemeyer
Hamid Mofid
Carsten Zornig
Eike-Christian Burandt
Alexander Stein
Andreas Block
Alexander E. Volk
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01283-2

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue